These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6681772)

  • 21. Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid.
    Kal HB; de Graaff E; Van Berkel AH; Goedoen HH
    In Vivo; 1992; 6(1):73-5. PubMed ID: 1385730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood flow distribution within transplantable tumours in the mouse.
    Fallowfield ME
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1683-8. PubMed ID: 2632252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the immune status of the TAR mouse on the growth and metastasis of tumour xenografts.
    Buckle AM; Goepel JR; Rees RC
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):663-74. PubMed ID: 3308478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of growth delay to cure for experimental tumour systems conforming to Poisson cure statistics.
    Wheldon TE; Brunton GF
    Br J Cancer; 1982 Jan; 45(1):1-9. PubMed ID: 7059451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.
    Parr I; Wheeler E; Alexander P
    Br J Cancer; 1973 May; 27(5):370-89. PubMed ID: 4713170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporary vascular occlusion and glucose: effects on tumour and normal tissue pH in animal experiments.
    van de Merwe SA; van den Berg-Blok AE; Kroon BB; van der Zee J; van den Berg AP
    Int J Hyperthermia; 1995; 11(6):829-39. PubMed ID: 8586904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice.
    Honess DJ; Dennis IF; Bleehen NM
    Radiother Oncol; 1993 Sep; 28(3):208-18. PubMed ID: 8255998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of BW12C on the radiosensitivity and necrosis of murine tissues and tumours.
    Stevens G; Hill SA; Joiner MC; Joiner B; Johns H; Williams K; Denekamp J; Nethersell AB
    Australas Radiol; 1994 Aug; 38(3):199-203. PubMed ID: 7945114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitation of nodal metastasis from a non-immunogenic murine carcinoma by previous whole-body irradiation of tumour recipients.
    Hewitt HB; Blake ER
    Br J Cancer; 1977 Jul; 36(1):23-34. PubMed ID: 329849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of recovery from potentially lethal damage on the determination of reoxygenation in a murine tumour.
    Sheldon PW; Fowler JF
    Br J Radiol; 1979 Aug; 52(620):634-41. PubMed ID: 486893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of tumour blood flow using the hypertensive agent, angiotensin II.
    Tozer GM; Shaffi KM
    Br J Cancer; 1993 May; 67(5):981-8. PubMed ID: 8494732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid.
    Hill SA; Sampson LE; Chaplin DJ
    Int J Cancer; 1995 Sep; 63(1):119-23. PubMed ID: 7558438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinca alkaloids: anti-vascular effects in a murine tumour.
    Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
    Eur J Cancer; 1993; 29A(9):1320-4. PubMed ID: 8343277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell kill and tumor control after heat treatment with and without vascular occlusion in RIF-1 tumors.
    Wallen CA; Colby TV; Stewart JR
    Radiat Res; 1986 May; 106(2):215-23. PubMed ID: 3704113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of growth of tumours in NC-cell-depleted mice with NC- and NK-cell-mediated lysis in vitro.
    Smart YC; Farrelly ML; Burton RC
    Int J Cancer; 1992 Mar; 50(5):817-21. PubMed ID: 1544715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative effects of the NOS inhibitor, Nomega-nitro-L-arginine, and the haemoxygenase inhibitor, zinc protoporphyrin IX, on tumour blood flow.
    Tozer GM; Prise VE; Motterlini R; Poole BA; Wilson J; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):849-53. PubMed ID: 9845109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of tumour response by calcium antagonists in the SCVII/St tumour implanted at two different sites.
    Wood PJ; Hirst DG
    Int J Radiat Biol; 1989 Sep; 56(3):355-67. PubMed ID: 2570820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.